In situ neuronal regeneration: the potential of astrocytes

References

[1] Wilson DM 3rd, Cookson MR, Van Den Bosch L, et al. Hallmarks of neurodegenerative diseases. Cell 2023;186:693–714.

[2] Chen X, Li H. Neuronal reprogramming in treating spinal cord injury. Neural Regener Res 2022;17:1440–5.

[3] Chen YC, Ma NX, Pei ZF, et al. A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion. Mol Ther 2020;28:217–34.

[4] Tai W, Wu W, Wang LL, et al. In vivo reprogramming of NG2 glia enables adult neurogenesis and functional recovery following spinal cord injury. Cell Stem Cell 2021;28:923–937.e4.

[5] Russo GL, Sonsalla G, Natarajan P, et al. CRISPR-mediated induction of neuron-enriched mitochondrial proteins boosts direct glia-to-neuron conversion. Cell Stem Cell 2021;28:584–34.e7.

[6] Wu Z, Parry M, Hou XY, et al. Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington’s disease. Nat Commun 2020;11:1105.

[7] Ge LJ, Yang FH, Li W, et al. In vivo neuroregeneration to treat ischemic stroke through NeuroD1 AAV-based gene therapy in adult non-human primates. Front Cell Dev Biol 2020;8:590008.

[8] Puls B, Ding Y, Zhang F, et al. Regeneration of functional neurons after spinal cord injury via in situ NeuroD1-mediated astrocyte-to-neuron conversion. Front Cell Dev Biol 2020;8:591883.

[9] Wang LL, Serrano C, Zhong X, et al. Revisiting astrocyte to neuron conversion with lineage tracing in vivo. Cell 2021;184:5465–5481.e16.

[10] Xu L, Xiang Z-Q, Guo Y-W, et al. Enhancing NeuroD1 Expression to Convert Lineage-Traced Astrocytes into Neurons. bioRxiv: the preprint server for biology. 2022:2022.06.21.496971.

RIGHTS & PERMISSIONS

The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.